Aja Health Announces Major Expansion in Virtual Care and Services

VANCOUVER, BC – January 23, 2026 – Aja Health and Wellness Inc. (TSXV:Aja) today unveiled a dual-pronged strategy aimed at significantly broadening its market presence and technological capabilities across Canada. The company announced a major distribution agreement for its comprehensive healthcare service, MyCare Ally, and a simultaneous significant software upgrade for its GOeVisit virtual health platform, signaling a push into specialized medical services like weight management programs.

These moves come as the Vancouver-based company navigates a competitive digital health landscape and works to overcome recent financial reporting challenges, positioning the announcements as critical steps in its growth trajectory.

Tapping a New Distribution Channel with Greatway Financial

Aja's wholly-owned subsidiary, Assured Diagnosis Inc. (ADI), has entered into a strategic broker agreement with Greatway Financial Inc., a large Insurance Managing General Agency (MGA) licensed to operate in every Canadian province except Quebec. According to the terms of the agreement, Greatway's extensive network of brokers will be authorized to market and sell enrollments for ADI's MyCare Ally program.

Greatway Financial, a substantial entity with an estimated annual revenue of nearly $500 million and over 1,600 employees, has historically focused on insurance and financial products. This partnership marks a notable expansion for the MGA into the distribution of direct health services. Greatway is expected to begin its marketing push for the program on February 7, 2026.

The MyCare Ally program is positioned as an all-in-one healthcare navigation service. It offers subscribers personalized support that includes initial diagnosis assistance, independent clinical reviews of medical cases, treatment summaries, and coordination for diagnostic imaging. A core component of the service is access to virtual medical care for over 450 minor illnesses through Aja's own GOeVisit platform. By leveraging Greatway’s established, nationwide sales infrastructure, Aja aims to rapidly scale its user base and bring its integrated health services to a much wider Canadian audience. This strategy bypasses the slow and costly process of building a direct-to-consumer sales force from the ground up, instead plugging into a ready-made distribution channel.

A Technological Leap for GOeVisit

Concurrent with its market expansion efforts, Aja is undertaking a critical technological overhaul of its GOeVisit virtual consultation platform. The company announced that its subsidiary, Aja Health Inc., will migrate the platform to a new Electronic Medical Records (EMR) software system, with the transition slated for completion by January 28, 2026.

While the company has not disclosed the name of the new EMR vendor, it has detailed the enhanced capabilities the upgrade will unlock. The new system is designed to support monitored health programs, specifically highlighting a new initiative for GLP-1 weight management drugs, a rapidly growing segment of the pharmaceutical market. This move places GOeVisit in a position to compete with specialized telehealth providers entering the lucrative weight-loss space.

Furthermore, the new EMR will enable expanded services including the facilitation of lab requisitions and a broader range of virtual testing services. This enhancement transforms GOeVisit from a platform primarily for straightforward consultations on minor illnesses into a more robust diagnostic and health management tool. The upgrade is a clear response to the evolving demands of the Canadian virtual healthcare market, where major players like Maple and Teladoc Health Canada have set a high bar for service diversity and accessibility. By adding these specialized functions, Aja is aiming to capture a more complex and potentially more profitable segment of the patient population.

A Strategic Push Amidst Financial Headwinds

These ambitious expansion plans are being executed against a backdrop of financial scrutiny for Aja Health and Wellness. The company, which has a current market capitalization of just under C$500,000, has been operating under a "Strong Sell" technical sentiment signal from market analysts. This follows a period of difficulty related to its financial disclosures.

In April 2025, the Alberta Securities Commission issued a management cease trade order (MCTO) against the company due to delays in filing its annual audited financial statements for the 2024 fiscal year. The company attributed the delay to complexities in accounting for a reverse takeover transaction. While the MCTO restricts trading by executives, it does not affect the public trading of Aja's stock on the TSX Venture Exchange.

Despite these challenges, the company has shown it can still secure capital, having announced a successful $1.125 million USD capital raise in October 2025 to fund growth and acquire U.S. marketing rights for other products. Today's announcements appear to be a continuation of that forward-looking strategy, focusing on strengthening its core Canadian digital health offerings.

In a statement regarding the developments, President and CEO Sanjeev Parsad expressed confidence on behalf of the Board of Directors. The combination of a powerful new distribution channel through Greatway Financial and the advanced technological capabilities of the upgraded GOeVisit platform represents a concerted effort by Aja to solidify its competitive position and accelerate its growth in Canada's dynamic healthcare sector.